MECOM was amplified in 19% of HNSCC patients in the TCGA Firehose cohort [39], yet the mechanism(s) of upregulation of EVI1 in HNSCC remain(s) to be determined. The gene discussed is MECOM; the disease is head and neck squamous cell carcinoma.